2-Picolinic Acid

2-Picolinic Acid

SCHEMBL3662471

CCOC(=O)CN(Cc1ccc(OC)cc1OC)Cc1c(-c2ccc(Br)o2)noc1C(=O)OCC.O=C(O)c1ccccn1

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.37
MAPT P10636 3/20 0.35
POLB P06746 2/20 0.35
ALDH1A1 P00352 7/20 0.34
KDM4E B2RXH2 5/20 0.34
TSHR P16473 1/20 0.34
PKM P14618 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
RAB9A P51151 2/20 0.32
NPC1 O15118 1/20 0.32
KMT2A Q03164 4/20 0.32
MEN1 O00255 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HTT P42858 1/20 0.32
HPGD P15428 3/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2777311 0.91 ALDH1A1 (0.38) PTPN1MAPTPOLBALDH1A1KDM4E
SCHEMBL2777556 0.84 PTPN1 (0.43) PTPN1MAPTPOLBALDH1A1KDM4E
SCHEMBL3663664 0.82 PTPN1 (0.41) PTPN1MAPTPOLBALDH1A1KDM4E
SCHEMBL2776138 0.81 POLB (0.47) PTPN1MAPTPOLBALDH1A1KDM4E
SCHEMBL2779106 0.81 POLB (0.41) PTPN1MAPTPOLBALDH1A1KDM4E
SCHEMBL2777595 0.78 TP53 (0.39) PTPN1MAPTPOLBALDH1A1KDM4E
SCHEMBL2776688 0.77 MEN1 (0.42) PTPN1MAPTPOLBALDH1A1KDM4E
SCHEMBL3663330 0.77 PTPN1 (0.38) PTPN1MAPTPOLBALDH1A1KDM4E
SCHEMBL2777421 0.76 SLC26A6 (0.43) PTPN1MAPTPOLBALDH1A1KDM4E
SCHEMBL3657976 0.75 POLB (0.39) PTPN1MAPTPOLBALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227475-A1 ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS Fibrogen, Inc. (US) 2010-09-15 EP disclosed
WO-2009073669-A1 ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS FIBROGEN, INC. (US) 2009-06-11 WO disclosed